The global chief of Teva Pharmaceuticals, world's largest generics drug maker, will visit India this month, in an indication of the growing attraction of India to global generic drug companies. Teva officials based in India said that Israel Makov, president and chief executive officer of the company, will be in the country by the end of this month. The impending visit has sparked off speculation about possible buyouts or investments by the Israeli giant. The Hyderabad-based Matrix has been at the centre of this buzz, with the stock surging 4.2% to Rs 229.05 on Wednesday as over 7 lakh shares changed hands.
Economic Times (http://economictimes.indiatimes.com/articleshow/1332766.cms)